Ethical considerations for HIV cure-related research at the end of life
Karine Dubé(University of California System), Davey M. Smith(University of California, San Diego), Brandon Brown(University of California, Riverside), Kushagra Mathur(University of California San Diego), Susan J. Little(University of California, San Diego), Stuart Luter(Department of Health), Sean Philpott‐Jones(Clarkson University), Sara Gianella(University of California San Diego), Sogol Stephanie Javadi(University of California San Diego), Hursch Patel(University of North Carolina at Chapel Hill), Andy Kaytes(Advisory Board Company (United States)), Anshula Nathan(University of North Carolina at Chapel Hill), Susan Concha-Garcia(University of California San Diego), Jeff Taylor(University of North Carolina at Chapel Hill)
Cited by 35
Related Papers
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
|Proceedings of the National Academy of Sciences|2003|1.2k
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
|New England Journal of Medicine|2002|1.1k